CAI
Clinical Asset Index
by VOS Supply Group
Drugs · acquisition-cost intelligence

Midazolam

· ingredient midazolam· MIDAZOLAM HYDROCHLORIDE 1 mg/mL; MIDAZOLAM HYDROCHLORIDE 5 mg/mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$0.23131
NADAC — pharmacy acquisition cost, not a retail/cash price

Acquisition-cost history

Weekly NADAC per ML — the trend nobody else shows. 8 weeks.

2025-02-192026-05-20

Same-ingredient options by acquisition cost

Other midazolam products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.

ProductNADAC / MLvs this
midazolam$0.23131+$0.00000
midazolam$0.55932+$0.32800
Midazolam Hydrochloride$0.67627+$0.44500

Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.